Back
Sonoma Pharmaceuticals Quote, Financials, Valuation and Earnings
Sponsored
SNOA
Sponsored
$50 trade to make today with huge potential!
Click here to access my #1 options strategy for overnight wins starting with $50!
Sell
24
SNOA
Sonoma Pharmaceuticals
Last Price:
0.15
Seasonality Move:
2.19%
7 Day Trial
ALL ACCESS PASS
$
7
20 Most Hated Stocks on Wall Street
Click here to see the full list and protect yourself before it's too late.Sonoma Pharmaceuticals Price Quote
$0.15
+0.00 (+0.54%)
(Updated: May 8, 2024 at 3:00 PM ET)
Sonoma Pharmaceuticals Key Stats
Sell
24
Sonoma Pharmaceuticals (SNOA)
is a Sell
Day range:
$0.14 - $0.16
52-week range:
$0.12 - $1.52
Dividend yield:
0%
P/E ratio:
0.00
P/S ratio:
0.08
P/B ratio:
0.35%
Volume:
186.6K
Avg. volume:
581.7K
1-year change:
-84.62%
Market cap:
$2.3M
Revenue:
$13.3M
EPS:
$-0.94
How Much Does Sonoma Pharmaceuticals Make?
-
How Much Are Sonoma Pharmaceuticals's Sales Annually?
SNOA Revenues are $13.3M -
How Much Profit Does Sonoma Pharmaceuticals's Make A Year?
SNOA net income is -$5.2M
Is Sonoma Pharmaceuticals Growing As A Company?
-
What Is Sonoma Pharmaceuticals's Growth Rate Quarterly?
Quarterly YoY revenue growth is 0.07% -
What Is Sonoma Pharmaceuticals's EPS Quarterly YoY Growth Rate?
Quarterly, year-over-year diluted EPS growth rate is 0%
Sonoma Pharmaceuticals Stock Price Performance
-
Did Sonoma Pharmaceuticals Stock Go Up Last Month?
Sonoma Pharmaceuticals share price went down by -2.04% last month -
Did SNOA's Share Price Rise Over The Last Year?
SNOA share price fell by -84.62% over the past 1 year
What Is Sonoma Pharmaceuticals 52-Week High & Low?
-
What Is Sonoma Pharmaceuticals’s 52-Week High Share Price?
Sonoma Pharmaceuticals has traded as high as $1.52 over the past 52 weeks -
What Is Sonoma Pharmaceuticals’s 52-Week Low Share Price?
Sonoma Pharmaceuticals has traded as low as $0.12 over the past 52 weeks
Sonoma Pharmaceuticals Price To Free Cash Flow
Data Unavailable
Is It Risky To Buy Sonoma Pharmaceuticals?
-
How Much Debt Does Sonoma Pharmaceuticals Have?
Total long term debt quarterly is $44K -
How Much Cash Does Sonoma Pharmaceuticals Have?
Cash and short term investments quarterly total is $2.4M -
What Is Sonoma Pharmaceuticals’s Book Value Per Share?
Book value per share is 0.49
Is Sonoma Pharmaceuticals Cash Flow Positive?
-
What Is SNOA Cash Flow From Operations?
Cash flow from operations (TTM) is -$5M -
What Is Sonoma Pharmaceuticals’s Cash Flow From Financing?
Cash flow from financing (TTM) is $4.4M -
What Is Sonoma Pharmaceuticals’s Cash Flow From Investing?
Cash flow from investing (TTM) is -$102K
Sonoma Pharmaceuticals Return On Invested Capital
-
Is Management Doing A Good Job?
SNOA return on invested capital is -74.41% -
What Is Sonoma Pharmaceuticals Return On Assets?
ROA measures how assets are converting to revenues and is -34.16% -
What Is SNOA Return On Equity?
ROE is a measure of profitability and is -76.57%
Sonoma Pharmaceuticals Earnings Date & Stock Price
-
What Is Sonoma Pharmaceuticals's Stock Price Today?
A single share of SNOA can be purchased today for 0.15 -
What Is Sonoma Pharmaceuticals’s Stock Symbol?
Sonoma Pharmaceuticals trades on the nasdaq under the ticker symbol: SNOA -
When Is Sonoma Pharmaceuticals’s Next Earnings Date?
The next quarterly earnings date for Sonoma Pharmaceuticals is scheduled on May 31, 2024 -
When Is SNOA's next ex-dividend date?
Sonoma Pharmaceuticals's next ex-dividend date is May 8, 2024 -
How To Buy Sonoma Pharmaceuticals Stock?
You can buy Sonoma Pharmaceuticals shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.
Sonoma Pharmaceuticals Competitors
-
Who Are Sonoma Pharmaceuticals's Competitors?
Below is a list of companies who compete with Sonoma Pharmaceuticals or are related in some way:
Sonoma Pharmaceuticals Dividend Yield
Data Unavailable
Sonoma Pharmaceuticals Analyst Estimates
YoY Growth | Past Surprise | |
---|---|---|
EPS: | 0% | 0% |
Revenue: | 6.59% | -16.54% |
Analyst Recommendations
Buy Recommendations: | 1 |
---|---|
Hold Recommendations: | 0 |
Sell Recommendations: | 0 |
Price Target: | 3.25 |
Upside from Last Price: | 2078.28% |